Back to search
FDAFDA · Food and drugs·Recall number D-0476-2024

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08

Published May 8, 2024 · Recall initiated: April 10, 2024

Summary

FDA records drug Class II recall D-0476-2024, published May 8, 2024 and initiated April 10, 2024. Recalling firm: Imprimis NJOF, LLC; Status: Ongoing; Reported quantity: 3320 bottles; Lot: Lot #: 23JUN031; Exp. 07/03/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Imprimis NJOF, LLC
Distributor
U.S. Nationwide
Lot
Lot #: 23JUN031; Exp. 07/03/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08 recalled?

Yes. FDA published recall D-0476-2024 on May 8, 2024. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter